Ranbaxy CEO says Daiichi Sankyo merger close to becoming a done deal
NEW DELHI Daiichi Sankyo and Ranbaxy mostly likely will close their merger deal by the end of December, Ranbaxy chief executive Malvinder Singh said Tuesday.
Tokyo-based Daiichi will pay $4.6 billion for Gurgaon, India-based Ranbaxy under a deal that was announced in June.
Recently, Ranbaxy faced a Food and Drug Administration ban on imports of drugs made at two of its plans into the United States when the FDA found manufacturing problems there; Ranbaxy has promised it will correct the violations. The company has also sought to branch into novel drug compounds and announced Monday that it would seek to begin clinical trials of a respiratory inflammation drug it had developed under a collaboration with GlaxoSmithKline; it has also entered a collaboration to develop anti-fungal and anti-bacterial drugs with Merck.
Walgreens ships diabetes supplies for free to Medicare Part B patients
DEERFIELD, Ill. Walgreens has announced that it ship diabetes testing supplies for free to people who have their supplies covered under Medicare Part B.
The move comes at a time when budgets are tight—especially for seniors. To make getting diabetes supplies easier and more affordable, Walgreens said, patients can pick up their testing items at one of the 6,400 stores or have supplies mailed to their home at no cost.
Those seniors who are eligible can sign up by calling 1-888-PARTB-65 (1-888-727-8265) or request a call from a Walgreens representative by logging on to https://www.walgreens.com/partb. Special Walgreens phone reps will assist with filing all of the necessary Part B claim forms and will answer any other additional questions, the company said.
Bruno’s, Food World stores announce closings of many in-store pharmacies
TUSCALOOSA, Ala. Bruno’s over the weekend announced that 22 out 40 in-store pharmacies in Bruno’s and Food World stored throughout Alabama and Florida will be closed. The closures will affect about 60 employees, the company said.
Bruno’s will sell remaining prescriptions and pharmaceutical inventories to CVS, a spokesman told the local media. CVS may also retain some of Bruno’s pharmacy employees.
No word yet on what Bruno’s will do with the remaining space in stores.